Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Manufacturing
Cellares, Ori dominate automated cell therapy production: report
The bulk of the field’s raised capital (81%) is held by Cellares and Ori Biotech, Tracxn said in a new report.
Fraiser Kansteiner
Jun 18, 2026 10:10am
Novo Nordisk opens Czech plant to produce next-gen obesity drugs
Jun 17, 2026 11:22am
CDMO Recipharm to pump ‘multi-million-dollar' investment into US
Jun 16, 2026 8:49am
Eisai gets UK backing as it expands plant for Leqembi production
Jun 15, 2026 10:20am
Teva to lay off 250 at for-sale API unit: report
Jun 10, 2026 10:56am
Hikma earmarks $267M to expand Ohio manufacturing, add 350 jobs
Jun 8, 2026 9:35am
